exenatide once monthly suspension / BMS  >>  Phase 2
Welcome,         Profile    Billing    Logout  

1 Trials

Remove FilterRemove Filter

 
Trial + Data / EventsStatusPhNRegionInterventionsSponsorConditionsPrimary complStudy compl
exenatide once monthly suspension / BMS
NCT01104701: A Study to Examine the Efficacy, Safety and Tolerability, and Pharmacokinetics of Exenatide Once Monthly Suspension

Checkmark Data
Jul 2011 - Jul 2011: Data
Checkmark Data
Mar 2011 - Mar 2011: Data
Completed
2
121
US
exenatide once weekly, exenatide once monthly suspension
AstraZeneca, Eli Lilly and Company
Type 2 Diabetes
12/10
12/10

Download Options